Essential lipid may modulate inflammation and aging, indicates new study

A study published in the Brazilian Journal of Surgery and Clinical Research presents a new model to explain how the fatty acid C15:0 acts in the body. The authors analyze clinical and metabolic data indicating that this essential lipid functions in a “triphasic” manner, modulating its action according to the dose and biological context.

An adaptive lipid

According to the research, low doses of C15:0 are associated with increased inflammation and low energy efficiency. In the intermediate range, considered ideal, the lipid activates regulatory pathways such as PPAR-α, AMPK, and CB2, promoting metabolic balance, reducing inflammatory markers, and improving cellular function. However, in excess, it can generate oxidative stress and loss of receptor sensitivity.

This multifaceted behavior brings C15:0 closer to endocannabinoids, which also vary their effects depending on the concentration. For the authors, this demonstrates that odd lipids have more flexible and adaptive functions than even lipids, traditionally linked to inflammatory responses when consumed or accumulated in excess.

Basis for new research

The study suggests that C15:0 may directly influence the so-called expanded endocannabinome, as part of it can be converted into C17:0 and give rise to neuroactive molecules.

This connection between nutrition, metabolism, and lipid signaling paves the way for new investigations into aging, chronic inflammation, and energy regulation. For the authors, understanding the triphasic role of these lipids can help develop more precise approaches to metabolic health and longevity, a field that is still advancing but gaining strength with increasing evidence of the importance of bioactive lipids in maintaining organism stability.